OBI Pharma and GlyTech have entered into a GlycOBI marketing agreement in Japan and a material transfer agreement

Date of occurrence of the event:2024/12/23 Counterparty to the contract or commitment: GlyTech, Inc. (Hereinafter referred to as “GlyTech”) Relationship with the Company:None Starting and ending dates (or rescission date) of the contract or commitment:2024/12/23 Major content (not applicable where rescinded):OBI Pharma and GlyTech have entered into a marketing agreement regarding GlycOBI antibody-drug conjugate (ADC) […]